Bosutinib - an effective and safe treatment option in the management of chronic myeloid leukemia

被引：3
作者：
Ercaliskan, Abdulkadir [1 ]
Eskazan, Ahmet Emre [1 ]
机构：
[1] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Div Hematol, Dept Internal Med, TR-34303 Istanbul, Turkey
来源：
FUTURE ONCOLOGY | 2020年 / 16卷 / 03期
关键词：
adverse event; bosutinib; chronic myeloid leukemia; comorbidity; imatinib; tyrosine kinase inhibitor; KINASE INHIBITOR TKI; IMATINIB; DASATINIB; DISCONTINUATION; NILOTINIB; THERAPY; CML;
D O I：
10.2217/fon-2020-0006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4425 / 4428
页数：4
相关论文
共 50 条
  • [31] Standard Management of Patients With Chronic Myeloid Leukemia
    Fava, Carmen
    Cortes, Jorge E.
    Kantarjian, Hagop
    Jabbour, Elias
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S382 - S390
  • [32] Practical Management of Patients With Chronic Myeloid Leukemia
    Cervantes, Francisco
    Mauro, Michael
    CANCER, 2011, 117 (19) : 4343 - 4354
  • [33] PHARMACOECONOMIC ANALYSIS OF CHRONIC MYELOID LEUKEMIA REMISSION WITHOUT TREATMENT
    Shuvaev, V. A.
    Abdulkadyrov, K. M.
    Turkina, A. G.
    Martynkevich, I. S.
    Chelysheva, E. Yu
    Fominykh, M. S.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2015, 60 (04): : 14 - 20
  • [34] BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach
    Menger, Jenna M.
    Sathianathen, Ryan S.
    Sakamoto, Kathleen M.
    Hijiya, Nobuko
    CURRENT ONCOLOGY REPORTS, 2024, 26 (03) : 250 - 257
  • [35] Current management and new treatment strategies of chronic myeloid leukemia
    Crysandt, Martina
    Bruemmendorf, Tim H.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (12) : 744 - 751
  • [36] A retrospective observational research study to describe the real-world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the Netherlands
    Claudiani, Simone
    Janssen, Jeroen J. W. M.
    Byrne, Jenny
    Smith, Graeme
    Blijlevens, Nicole
    Raghavan, Manoj
    Smith, Matthew
    Clark, Richard E.
    Mclain-Smith, Susan
    Carter, Angela M.
    Milojkovic, Dragana
    Apperley, Jane F.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (01) : 90 - 99
  • [37] Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review
    Jorge E. Cortes
    Jane F. Apperley
    Daniel J. DeAngelo
    Michael W. Deininger
    Vamsi K. Kota
    Philippe Rousselot
    Carlo Gambacorti-Passerini
    Journal of Hematology & Oncology, 11
  • [38] Family Planning and Pregnancy in Patients with Chronic Myeloid Leukemia
    Berman, Ellin
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2023, 18 (02) : 33 - 39
  • [39] A phase 1/2 study of bosutinib in Japanese adults with Philadelphia chromosome-positive chronic myeloid leukemia
    Nakaseko, Chiaki
    Takahashi, Naoto
    Ishizawa, Kenichi
    Kobayashi, Yukio
    Ohashi, Kazuteru
    Nakagawa, Yasunori
    Yamamoto, Kazuhito
    Miyamura, Koichi
    Taniwaki, Masafumi
    Okada, Masaya
    Kawaguchi, Tatsuya
    Shibata, Atsushi
    Fujii, Yosuke
    Ono, Chiho
    Ohnishi, Kazunori
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101 (02) : 154 - 164
  • [40] A Review of the Therapeutic Role of Bosutinib in Chronic Myeloid Leukemia
    Kantarjian, Hagop M.
    Jabbour, Elias J.
    Lipton, Jeffrey H.
    Castagnetti, Fausto
    Bruemmendorf, Tim H.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (05) : 285 - 297
12345